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Hydrophobic macromolecular contrast agents (MMCAs) are highly desirable to
provide safe and efficient magnetic resonance (MR) visibility to implantable medical
devices. In this study, we report on the synthesis and evaluation of novel
biodegradable poly(ε-caprolactone)-based MMCAs. Poly(α-propargyl-ε-caprolactone-
co-ε-caprolactone)s containing 2, 5, and 10 mol % of propargyl groups have been
prepared by ring-opening copolymerization of ε-caprolactone and the corresponding
propargylated lactone. In parallel, a diazido derivative of the clinically used
diethylenetriaminepentaacetic acid (DTPA)/Gd(3+) complex has been synthesized.
Finally, MRI-visible poly(ε-caprolactone)s (PCLs) were obtained by the efficient click
ligation of these compounds via a Cu(I)-catalyzed [3 + 2] cycloaddition. ICP-MS
analyses confirmed the efficient coupling of the complex on the PCL backbone with
the MRI-visible PCLs containing 1.0, 2.6, and 3.6 wt % of Gd(3+). The influence of
the Gd(3+) grafting density on the T1 relaxation times and on the MRI visibility of
the novel biodegradable MMCAs was evaluated. Finally, their stability and
cytocompatibility were assessed with regard to their potential as innovative MRI-
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